Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | DIVA 58" Medical Display is Now FDA-ApprovedQUBYX PerfectLum Calibration and QA Software Bundled with DIVA 8MP Display Receives FDA 510(k) Clearance for Diagnostic Viewing
By: QUBYX Software Technologies Inc. “We are extremely happy with FDA's decision to approve the DIVA & PerfectLum Bundle.” - says Marc Leppla, Director and CTO of QUBYX. “Our long-term partnership with DIVA has become very rewarding this year.” DIVA ZSP5812CMI overview DIVA ZSP5812CMI is a 58” 8MP monitor with a resolution of 3840x2160 pixels and a typical brightness of 400 cd/m2 which is designed specifically for the demanding medical imaging environment. This leading-edge solution is an ideal choice for soft-copy reading and better image interpretation. PerfectLum software overview QUBYX PerfectLum is a calibration and quality control application that significantly enhances the performance of any display in accordance with medical imaging requirements, including NEMA DICOM part 14 GSDF. The software also performs acceptance and constancy tests to verify that the display conforms to such regulations as AAPM TG18, new DIN 6868-157, JESRA X-0093, IEC 62563-1, ACR, NY State PDM and NY City PDM Guidelines. See more at: http://qubyx.com/ According to the recently issued FDA 510(k) clearance, the bundle of DIVA ZSP5812CMI monitor & QUBYX PerfectLum is intended to be used for displaying and viewing medical images, for review and analysis by trained medical practitioners. About QUBYX QUBYX Software Technologies Inc., a software manufacturer providing the new dimension of image quality in the medical imaging industry and display calibration field since 2002. About DIVA DIVA specializes in designing and manufacturing TFT-LCD displays for special applications, as well as customized design requests, supported by good quality documentation. For more information about DIVA, please visit www.diva.com.tw End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|